Mounting evidence suggests that they play overarching roles in PCa initiation, progression and AR targeted therapy resistance [28,29], suggesting that eradication of this tiny population may be a promising strategy to fight against PCa. This evidence concerns the gene AR and posterior cortical atrophy.